The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(3-(3-allyl-4-((4-(trifluoromethyl)benzyl)oxy)phenyl)-1,2,4-oxadiazol-5yl)pyrrolidine-1-carboximidamide hydrochloride ID: ALA4473353
PubChem CID: 155536233
Max Phase: Preclinical
Molecular Formula: C24H25ClF3N5O2
Molecular Weight: 471.48
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CCc1cc(-c2noc([C@@H]3CCCN3C(=N)N)n2)ccc1OCc1ccc(C(F)(F)F)cc1.Cl
Standard InChI: InChI=1S/C24H24F3N5O2.ClH/c1-2-4-16-13-17(21-30-22(34-31-21)19-5-3-12-32(19)23(28)29)8-11-20(16)33-14-15-6-9-18(10-7-15)24(25,26)27;/h2,6-11,13,19H,1,3-5,12,14H2,(H3,28,29);1H/t19-;/m0./s1
Standard InChI Key: VXZXHBSDHBGGAP-FYZYNONXSA-N
Molfile:
RDKit 2D
35 37 0 0 0 0 0 0 0 0999 V2000
14.9667 -3.8073 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.9904 -5.5891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5048 -8.5476 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.9380 -7.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7507 -3.0737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7748 -5.0521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1841 -5.7637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3552 -3.3805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2237 -8.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7325 -4.4306 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4043 -5.5840 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5104 -6.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5091 -7.7292 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.5389 -4.2559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3685 -7.7277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2242 -8.9663 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.2234 -5.2557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6571 -8.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0736 -4.7683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6517 -5.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2252 -6.9087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6533 -6.4913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5116 -5.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3667 -6.9067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1415 -3.6299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7956 -6.9078 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9391 -6.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9540 -4.9689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9416 -6.4954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9388 -5.6648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3187 -4.4357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0815 -6.4947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2250 -7.7259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5172 -8.1343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5170 -8.9515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 1 0
21 29 2 0
29 30 1 0
12 21 1 0
26 32 1 0
2 19 1 0
23 12 2 0
25 8 1 0
15 24 1 0
11 28 2 0
10 20 2 0
28 14 1 0
9 13 1 0
7 2 1 0
20 11 1 0
4 18 1 0
6 28 1 1
19 31 1 0
4 9 1 0
17 23 1 0
12 26 1 0
31 25 1 0
18 15 2 0
30 17 2 0
9 16 1 0
22 27 1 0
32 24 1 0
24 22 2 0
30 20 1 0
14 10 1 0
31 6 1 0
9 3 1 0
25 5 2 0
27 4 2 0
21 33 1 0
33 34 1 0
34 35 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 471.48Molecular Weight (Monoisotopic): 471.1882AlogP: 5.09#Rotatable Bonds: 7Polar Surface Area: 101.26Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 11.17CX LogP: 5.86CX LogD: 3.40Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.28Np Likeness Score: -1.00
References 1. Sibley CD, Morris EA, Kharel Y, Brown AM, Huang T, Bevan DR, Lynch KR, Santos WL.. (2020) Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity., 63 (3): [PMID:31895563 ] [10.1021/acs.jmedchem.9b01508 ]